ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Sensei Biotherapeutics Inc

Sensei Biotherapeutics Inc (SNSE)

1.05
-0.04
(-3.67%)
Closed March 29 04:00PM
1.06
0.01
(0.95%)
After Hours: 07:59PM

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
1.05
Bid
0.95
Ask
1.10
Volume
16,948
1.06 Day's Range 1.12
0.51 52 Week Range 1.926
Market Cap
Previous Close
1.09
Open
1.10
Last Trade
5
@
0.95
Last Trade Time
Financial Volume
$ 18,440
VWAP
1.088
Average Volume (3m)
53,631
Shares Outstanding
25,070,980
Dividend Yield
-
PE Ratio
-0.78
Earnings Per Share (EPS)
-1.36
Revenue
-
Net Profit
-34.1M

About Sensei Biotherapeutics Inc

Sensei Biotherapeutics Inc is a clinical-stage immunotherapy company. It is engaged in the discovery and development of next-generation therapies with an initial focus on treatments for cancer. The company's ImmunoPhage platform is a powerful, self-adjuvanted and highly differentiated immunotherapy ... Sensei Biotherapeutics Inc is a clinical-stage immunotherapy company. It is engaged in the discovery and development of next-generation therapies with an initial focus on treatments for cancer. The company's ImmunoPhage platform is a powerful, self-adjuvanted and highly differentiated immunotherapy approach that is designed to utilize bacteriophage to induce a robust, focused, and coordinated innate and adaptive immune response. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Dover, Delaware, USA
Founded
1970
Sensei Biotherapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker SNSE. The last closing price for Sensei Biotherapeutics was $1.09. Over the last year, Sensei Biotherapeutics shares have traded in a share price range of $ 0.51 to $ 1.926.

Sensei Biotherapeutics currently has 25,070,980 shares outstanding. The market capitalization of Sensei Biotherapeutics is $26.58 million. Sensei Biotherapeutics has a price to earnings ratio (PE ratio) of -0.78.

SNSE Latest News

Form 8-K - Current report

false 0001829802 0001829802 2024-03-05 2024-03-05 0001829802 us-gaap:CommonStockMember 2024-03-05 2024-03-05 0001829802 us-gaap:SeriesAPreferredStockMember 2024-03-05 2024-03-05    ...

Form 8-K - Current report

true false 0001829802 0001829802 2024-02-28 2024-02-28 0001829802 dei:FormerAddressMember 2024-02-28 2024-02-28 0001829802 us-gaap:CommonStockMember 2024-02-28 2024-02-28 0001829802...

Form 4 - Statement of changes in beneficial ownership of securities

SEC Form 4 FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIPFiled pursuant to Section 16(a) of the Securities Exchange...

Form 4 - Statement of changes in beneficial ownership of securities

SEC Form 4 FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIPFiled pursuant to Section 16(a) of the Securities Exchange...

Form 4 - Statement of changes in beneficial ownership of securities

SEC Form 4 FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIPFiled pursuant to Section 16(a) of the Securities Exchange...

Form 8-K - Current report

false 0001829802 0001829802 2024-02-05 2024-02-05 0001829802 us-gaap:CommonStockMember 2024-02-05 2024-02-05 0001829802 us-gaap:SeriesAPreferredStockMember 2024-02-05 2024-02-05    ...

Form 8-K - Current report

false 0001829802 0001829802 2024-01-04 2024-01-04 0001829802 us-gaap:CommonStockMember 2024-01-04 2024-01-04 0001829802 us-gaap:SeriesAPreferredStockMember 2024-01-04 2024-01-04    ...

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

falsetrueQ30001829802--12-31P1Ytwo yearsthree yearsDecember 30, 20220001829802us-gaap:GeneralAndAdministrativeExpenseMember2022-01-012022-09-300001829802snse:UnvestedRestrictedStockUnitsMember2022...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.02-1.86915887851.071.221.01738661.12403726CS
40.21250.841.220.79852580.98939505CS
120.2836.36363636360.771.220.71536310.90275453CS
260.265833.89441469010.78421.220.51607930.78179296CS
52-0.28-21.05263157891.331.9260.51542681.11342634CS
156-12.02-91.966335118613.0715.180.51750884.87660968CS
260-23.65-95.748987854324.726.380.51860117.1286538CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
AVTXAvalo Therapeutics Inc
$ 22.08
(364.84%)
31.9M
NXLNexalin Technologies Inc
$ 1.50
(92.31%)
11.67M
CEROCERo Therapeutics Holdings Inc
$ 3.112
(90.92%)
24.08M
BDRXBiodexa Pharmaceuticals PLC
$ 1.6201
(88.60%)
88.37M
KYCHKeyarch Acquisition Corporation
$ 12.30
(75.58%)
196.62k
BOLDBoundless Bio Inc
 14.25
(-76.24%)
767.63k
PMECPrimech Holdings Ltd
$ 1.2999
(-66.50%)
8.28M
TNXPTonix Pharmaceuticals Holding Corporation
$ 0.1816
(-44.45%)
21.92M
GMDAGamida Cell Ltd
$ 0.036
(-39.19%)
89.18M
NBSTWNewbury Street Acquisition Corporation
$ 0.042279
(-38.28%)
1.75k
NKLANikola Corporation
$ 1.035
(13.85%)
163.84M
GMDAGamida Cell Ltd
$ 0.036
(-39.19%)
89.18M
BDRXBiodexa Pharmaceuticals PLC
$ 1.6201
(88.60%)
88.37M
MARAMarathon Digital Holdings Inc
$ 22.56
(2.22%)
86.14M
AKANAkanda Corporation
$ 0.1166
(-29.29%)
80.34M

Your Recent History

Delayed Upgrade Clock